Evidence for Antibody-Mediated Enhancement of Simian Immunodeficiency Virus (SIV) Gag Antigen Processing and Cross Presentation in SIV-Infected Rhesus Macaques

Documenti analoghi

• Administration of Recombinant Rhesus Interleukin-12 during Acute Simian Immunodeficiency Virus (SIV) Infection Leads to Decreased Viral Loads Associated with Prolonged Survival in SIVmac251-Infected Rhesus Macaques
  di: Ansari, A. A., et al.
  Pubblicazione: (2002)
• Simian Immunodeficiency Virus (SIV) Infection Influences the Level and Function of Regulatory T Cells in SIV-Infected Rhesus Macaques but Not SIV-Infected Sooty Mangabeys
  di: Pereira, L. E., et al.
  Pubblicazione: (2007)
• Dysregulation of the Polo-Like Kinase Pathway in CD4(+) T Cells Is Characteristic of Pathogenic Simian Immunodeficiency Virus Infection
  di: Bostik, Pavel, et al.
  Pubblicazione: (2004)
• Replication-Competent Simian Immunodeficiency Virus (SIV) Gag Escape Mutations Archived in Latent Reservoirs during Antiretroviral Treatment of SIV-Infected Macaques
  di: Queen, Suzanne E., et al.
  Pubblicazione: (2011)
• Identification of Protein Kinases Dysregulated in CD4(+) T Cells in Pathogenic versus Apathogenic Simian Immunodeficiency Virus Infection
  di: Bostik, Pavel, et al.
  Pubblicazione: (2001)